4-Ethoxyphenyl trans-4-Butylcyclohexanecarboxylate>98.0%(GC)100g

Methyl (4aS,6aR,6bR,8aR,10S,12aR,12bR,14aR,14bS)-10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-14-oxoicosahydropicene-4a(2H)-carboxylate, 98%, 500mg

Objetivo de estaño 99,999% dia. 101,6 mm x espesor 6,35 mm 1 ud.

1-tert-Butyloxycarbonyl-4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine, 95.0%, 5g

5,6-Dibromonicotinonitrile, 95%, 25g

2-Bromo-4-fluoro-1-(methylthio)benzene, 95.0%, 5g

4-Iodo-N,N-dimethyl-1H-imidazole-1-sulfonamide, 95.0%, 1g

6-Hydroxy-1-isopropyl-4-(4-isopropylphenyl)-1H-quinazolin-2-one, 97%, 100mg

3,6-Dimethylpiperazine-2,5-dione, 95.0%, 1g

4-Bromo-5-methylbenzo[d]thiazol-2-amine, 98%, 25g

DARIFENACIN HBR, 99%, 100mg

Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-, 98%, 50mg

6-(Thiophen-3-yl)nicotinaldehyde, 95%, 1g